Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
42,305,413
-
Share change
-
+348,169
-
Total reported value
-
$14,003,877,662
-
Put/Call ratio
-
76%
-
Price per share
-
$331.24
-
Number of holders
-
480
-
Value change
-
+$110,794,797
-
Number of buys
-
217
-
Number of sells
-
226
Institutional Holders of ABIOMED INC - COMMON STOCK (ABMD) as of Q1 2022
As of 31 Mar 2022,
ABIOMED INC - COMMON STOCK (ABMD) was held by
480 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,305,413 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., BAILLIE GIFFORD & CO, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, PRIMECAP MANAGEMENT CO/CA/, RENAISSANCE TECHNOLOGIES LLC, BROWN CAPITAL MANAGEMENT LLC, GENERATION INVESTMENT MANAGEMENT LLP, and ALLIANCEBERNSTEIN L.P..
This page lists
480
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.